Search results
Results from the WOW.Com Content Network
Rubella vaccine is a vaccine used to prevent rubella. [1] Effectiveness begins about two weeks after a single dose and around 95% of people become immune. Countries with high rates of immunization no longer see cases of rubella or congenital rubella syndrome .
The vaccine is now usually given as part of the MMR vaccine. The WHO recommends the first dose be given at 12 to 18 months of age with a second dose at 36 months. Pregnant women are usually tested for immunity to rubella early on. Women found to be susceptible are not vaccinated until after the baby is born because the vaccine contains live virus.
This is an accepted version of this page This is the latest accepted revision, reviewed on 20 December 2024. Combined vaccine against measles, mumps, and rubella Pharmaceutical compound MMR vaccine MMR vaccine Combination of Measles vaccine Vaccine Mumps vaccine Vaccine Rubella vaccine Vaccine Clinical data Trade names M-M-R II, Priorix, Tresivac, others Other names MPR vaccine AHFS / Drugs ...
This is an accepted version of this page This is the latest accepted revision, reviewed on 8 January 2025. Administration of a vaccine to protect against disease This article is about administration of a vaccine. For the vaccines themselves, see vaccine. See also: Immunization Medical intervention Vaccinations Girl about to be vaccinated in her upper arm ICD-9-CM 99.3 - 99.5 [edit on Wikidata ...
For this there are two different vaccines, the MMR and the MMRV. The MMR protects against measles, mumps and rubella and is given in 2 doses between 12 and 15 months of age. The MMRV protects against measles, mumps, rubella and varicella. [48] Some side effects of the MMR vaccine are [2] fever (1 in 6) mild rash (1 in 20)
For premium support please call: 800-290-4726 more ways to reach us
The other additions in UIP through the way are inactivated polio vaccine (IPV), rotavirus vaccine (RVV), Measles-Rubella vaccine (MR). Four new vaccines have been introduced into the country's Universal Immunisation Programme (UIP), including injectable polio vaccine, an adult vaccine against Japanese Encephalitis and Pneumococcal Conjugate ...
use of vaccines and other immunobiologic agents in clinical practice or preventive medicine; clinical or laboratory vaccine research; assessment of vaccine efficacy and safety; consumer perspectives and/or social and community aspects of immunization programs; at least one member must be an expert in this category.